Is there an Indian version of Pralsetinib?

Pralsetinib (Pralsetinib) currently has no Indian version of its generic version on the market. PlatinibNot yet approved for other indications in China, the United States or Europe, platinibis a daily oral targeted therapy that may block a protein called receptor transfection (RET). RET fusions lead to uncontrolled cell growth and cancer. By inhibiting RET, this drug can slow or stop tumor growth.

The U.S. Food and Drug Administration (FDA) approved platinib for the treatment of three indications: adult patients with metastasis-positive non-small cell lung cancer detected in an FDA-approved study, adult and pediatric patients 12 years and older with advanced or metastatic RET MTC mutations, and adult and pediatric patients 12 years and older with advanced or metastatic thyroid-positive cancer who require systemic therapy and are refractory to treatment with radioactive iodine, if radioactive iodine is appropriate.

It is understood that the original drug Platinib has been launched in China, but it has not yet entered the scope of medical insurance. The price of each box of 100mg*120 tablets may be around 60,000 yuan, which is expensive. The price of the European version of 100mg*60 capsules sold overseas may be around 40,000 yuan per box, and the price of the American version may be around 150,000 yuan per box (prices may fluctuate due to exchange rates). The ingredients of domestic and foreign original drugs are basically the same. There is currently no generic version of Platinib available on the market. Please consult your medical consultant for specific prices and drug details.